# Perfect Moment Ltd.: overview PMNT · OTC · CIK 1849221 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/pmnt.md) · [Financials](/companies/pmnt/financials.md) · [Filings](/companies/pmnt/filings.md) · [Insiders](/companies/pmnt/insiders.md) Latest reported revenue: [$1.1m](/filings/0001493152-26-038291.md) for Q1 FY2027, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-038291). ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [3.8](/filings/0001493152-25-022322.md) | [11.7](/filings/0001493152-26-006292.md) | [5.0 d](/filings/0001493152-26-030418.md) | [1.5](/filings/0001493152-26-038291.md) | [4.8](/filings/0001493152-25-022322.md) | [11.7](/filings/0001493152-26-006292.md) | [5.7 d](/filings/0001493152-26-030418.md) | [1.2](/filings/0001493152-26-038291.md) | | Gross margin | % | [54.0%](/filings/0001493152-25-022322.md) | [54.8%](/filings/0001493152-26-006292.md) | [32.0% d](/filings/0001493152-26-030418.md) | [60.4%](/filings/0001493152-26-038291.md) | [60.1%](/filings/0001493152-25-022322.md) | [64.4%](/filings/0001493152-26-006292.md) | [83.0% d](/filings/0001493152-26-030418.md) | [54.5%](/filings/0001493152-26-038291.md) | | Operating margin | % | [(66.7%)](/filings/0001493152-25-022322.md) | [(11.1%)](/filings/0001493152-26-006292.md) | [(130.1%) d](/filings/0001493152-26-030418.md) | [(207.5%)](/filings/0001493152-26-038291.md) | [(23.9%)](/filings/0001493152-25-022322.md) | [5.0%](/filings/0001493152-26-006292.md) | [(28.6%) d](/filings/0001493152-26-030418.md) | [(283.5%)](/filings/0001493152-26-038291.md) | | Net margin | % | [(71.6%)](/filings/0001493152-25-022322.md) | [(21.3%)](/filings/0001493152-26-006292.md) | [(145.5%) d](/filings/0001493152-26-030418.md) | [(259.4%)](/filings/0001493152-26-038291.md) | [(38.6%)](/filings/0001493152-25-022322.md) | [0.8%](/filings/0001493152-26-006292.md) | [(27.4%) d](/filings/0001493152-26-030418.md) | [(307.2%)](/filings/0001493152-26-038291.md) | | Diluted EPS | $ per share | [(0.17)](/filings/0001493152-25-022322.md) | [(0.15)](/filings/0001493152-26-006292.md) | not reported | [(0.21)](/filings/0001493152-26-038291.md) | [(0.06)](/filings/0001493152-25-022322.md) | [0.00](/filings/0001493152-26-006292.md) | not reported | [(0.07)](/filings/0001493152-26-038291.md) | | Free cash flow | $m | [(3.9) d](/filings/0001493152-25-022322.md) | [(1.2) d](/filings/0001493152-26-006292.md) | [(1.1) d](/filings/0001493152-26-030418.md) | not reported | not reported | [2.2 d](/filings/0001493152-26-006292.md) | [(0.3) d](/filings/0001493152-26-030418.md) | [(3.3)](/filings/0001493152-26-038291.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | [23.4](/filings/0001493152-24-025792.md) | [24.4](/filings/0001641172-25-017186.md) | [21.5](/filings/0001493152-26-030418.md) | [23.6](/filings/0001493152-26-030418.md) | | Gross margin | % | [37.4%](/filings/0001493152-24-025792.md) | [50.9%](/filings/0001641172-25-017186.md) | [48.5%](/filings/0001493152-26-030418.md) | [67.6%](/filings/0001493152-26-030418.md) | | Operating margin | % | [(36.8%)](/filings/0001493152-24-025792.md) | [(31.4%)](/filings/0001641172-25-017186.md) | [(64.2%)](/filings/0001493152-26-030418.md) | [(22.2%)](/filings/0001493152-26-030418.md) | | Net margin | % | [(44.0%)](/filings/0001493152-24-025792.md) | [(35.7%)](/filings/0001641172-25-017186.md) | [(74.1%)](/filings/0001493152-26-030418.md) | [(30.2%)](/filings/0001493152-26-030418.md) | | Diluted EPS | $ per share | [(2.16)](/filings/0001493152-24-025792.md) | [(1.34)](/filings/0001641172-25-017186.md) | [(0.99)](/filings/0001493152-26-030418.md) | [(0.23)](/filings/0001493152-26-030418.md) | | Free cash flow | $m | [(3.8)](/filings/0001493152-24-025792.md) | [(4.7)](/filings/0001641172-25-017186.md) | [(10.2)](/filings/0001493152-26-030418.md) | [(9.4)](/filings/0001493152-26-030418.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pmnt/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) None of the funds in coverage reports a position in its latest 13F. ## Recent filings [All 187 filings](/companies/pmnt/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-15 | 20:30 ET | [8-K](/filings/0001493152-26-047258.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-047258 | | 2026-08-17 | 21:00 ET | [8-K](/filings/0001493152-26-038779.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-038779 | | 2026-08-14 | 20:00 ET | [10-Q](/filings/0001493152-26-038291.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038291 | | 2026-07-06 | 21:00 ET | [8-K](/filings/0001493152-26-032192.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-032192 | | 2026-06-29 | 12:00 ET | [10-K](/filings/0001493152-26-030418.md) | Annual report, period 2026-03-31 | 0001493152-26-030418 | | 2026-06-16 | 21:19 ET | [8-K](/filings/0001493152-26-028921.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-028921 | | 2026-06-12 | 21:27 ET | [8-K](/filings/0001493152-26-028535.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028535 | | 2026-05-12 | 21:00 ET | [8-K](/filings/0001493152-26-022520.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-022520 | | 2026-04-14 | 16:56 ET | [8-K](/filings/0001493152-26-016510.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-016510 | | 2026-03-30 | 20:06 ET | [8-K](/filings/0001493152-26-013556.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-013556 | ## Latest annual report [Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001493152-26-030418.md), filed Jun 29, 2026. ## Forecast league Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/d4cc9865-8f2e-4eb4-a158-bc3ff946e4c7) ## About the filer - CIK: 1849221 - Tickers: PMNT - Exchange: OTC - SIC code: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.